Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-18 @ 6:49 PM
Study NCT ID:
NCT04058067
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2019-08-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-14
First Submit QC Date:
None
Study First Post Date:
2019-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-01
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL